Introduction
NURS FPX 9020 Assessment 1 The Croaker of Nursing Practice (DNP) design performance phase is the practical operation of confirmation-tested results to ameliorate clinical issues. This paper details the performance process of a nanny-led digital hypertension operation program designed to enhance drug adherence and blood pressure control in grown-ups with habitual hypertension. The discussion covers design objects, performance procedures, outgrowth measures, challenges, and assignments learned from the performance phase.
Project Overview and Purpose
The DNP design aimed to ameliorate drug adherence and hypertension control among adult cases through a digital adherence intervention combining nanny coaching, mobile monuments, and patient education.
Objectives:
- Increase drug adherence scores by 25 over 12 weeks.
- Meliorate means systolic blood pressure (SBP) by at least 10 mmHg.
- Strengthen nanny-case communication and digital engagement.
This design aligns with Healthy People 2030 pretensions of reducing hypertension-related morbidity through better treatment adherence (U.S. Department of Health and Human Services (HHS), 2021).
Implementation Setting and Participants
The design was executed in a primary care clinic serving roughly 2,500 adult cases.
Actors included 30 grown-ups aged 30–70 times diagnosed with hypertension, taking at least one antihypertensive drug, and retaining a smartphone compatible with the mobile adherence app.
Inclusion Criteria
- Diagnosed hypertension (≥ 140/90 mmHg)
- specified drug for at least six months
- Access to digital technology
Exclusion Criteria
- Cognitive impairments
- incapability to concurrence
- Participation in other adherence studies
Implementation Procedures
Phase 1: Preparation (Weeks 1–2)
- attained Institutional Review Board (IRB) blessing.
- Conducted nanny training on digital adherence tools.
- Configured mobile memorial systems and EHR integration.
- Developed educational paraphernalia on drug adherence.
Phase 2: Recruitment and Baseline Data Collection (Weeks 3–4)
- signed 30 actors via clinic referrals.
- attained informed concurrence.
- Recorded birth BP readings and MMAS-8 (Morisky Medication Adherence Scale) scores.
Phase 3: Intervention (Weeks 5–12)
- Actors entered substantiated nanny guiding sessions and app setup backing.
- Nurses conducted daily telehealth follow-ups to address cascade.
- Mobile monuments transferred daily drug cautions.
Phase 4: Post-Implementation Evaluation (Weeks 13–14)
- Collected follow-up BP readings and MMAS-8 scores.
- We conducted semi-structured interviews to gather perceptivity from the party guests.
Evaluation of Outcomes
Quantitative Results
After 12 weeks
- Drug adherence was bettered by a norm of 30, with MMAS-8 scores rising from 5.2 to 7.1 (p < 0.05).
- Systolic blood pressure dropped from a mean of 146 mmHg to 134 mmHg.
- Diastolic blood pressure bettered modestly from 90 to 84 mmHg.
Qualitative Results
Three main themes surfaced.
- commission through technology – Cases felt in control of their health.
- Nanny-case cooperation—nonstop engagement bettered responsibility.
- Ease of digital integration – App monuments reduced obliviousness.
Challenges and Barriers
Technology Literacy
Some actors plodded originally with app setup, taking extended nanny backing.
Engagement Decline
Engagement slightly dropped in the final two weeks, pressing the need for sustained provocation strategies.
Workflow Integration
Nurses reported time constraints during case follow-up calls; future integration into EHR workflow robotization is recommended.
Ethical and Legal Considerations
- Informed concurrence was attained before participation.
- Confidentiality was maintained through de-identified data storage.
- Voluntary participation was emphasized.
- Data security complied with HIPAA regulations.
Sustainability and Dissemination Plan
Sustainability
- Incorporate the mobile adherence app into the clinic’s habitual complaint operation program.
- Train nursing staff for ongoing use beyond design completion.
- Examiner adherence criteria daily as part of quality enhancement (QI) enterprise.
Dissemination
- donation to clinic leadership and quality enhancement commission.
- Submission to The Journal of Nursing Care Quality for publication.
- Bill donation at the American Association of Nurse Interpreters (AANP) Conference.
Conclusion
The DNP design successfully demonstrated that nanny-led digital adherence programs can significantly meliorate drug adherence and blood pressure control. The combination of nursing engagement, digital monuments, and patient education produced measurable advancements and positive feedback. Unborn enterprises should concentrate on gauging this model to other habitual complaint populations similar to diabetes and heart failure.
References
Bosworth, H. B., Olsen, M. K., & Granger, B. B. (2021). medicine adherence A call for bettered measures to align with the patient experience. American Heart Journal, 240, 34–40 https://doi.org/10.1016/j.ahj.2021.06.006
Chen, Y., Li, J., & Wang, Z. (2022). Effectiveness of mobile-predicated interventions on medicine adherence in cases with hypertension A meta-analysis. Journal of Hypertension, 40(6), 1248–1257. https://doi.org/10.1097/HJH.0000000000003098
Johnson, R. L., Evans, P., & Clark, J. (2022). Team-predicated interventions to meliorate medicine adherence among hypertensive grown-ups. Primary Care Nursing Journal, 29(2), 145–153.
Li, X., Zhou, Q., & Zhang, H. (2023). The part of mobile health in managing hypertension Integrating technology into nursing practice. Digital Health Nursing, 7(1), 12–20.
Department of Health and Human Services (2021). Healthy People 2030 objects to high blood pressure.
Overview
NURS FPX 9020 Assessment 1 design performance in practice requires DNP scholars to demonstrate their capability to execute a design, collect and dissect data, and estimate real-world issues. The paper focuses on putting the proposed plan into practice, agitating results, challenges, and coming down.
Step-by-Step Guide: How to Complete NURS FPX 9020 Assessment 1
Step 1: Review Your Approved Project Plan
Ensure your performance aligns with your previously approved NURS FPX 9010 plan.
Step 2: Describe the Setting and Participants
Give a clear description of the clinical point, addition/rejection criteria, and recovery styles.
Step 3: Outline Implementation Procedures
Describe phases, timelines, and arrears using clear, step-by-step details.
Step 4: Present Data Collection and Analysis
Include both quantitative and qualitative measures (e.g., adherence scores, patient interviews).
Step 5: Report Results
Include both quantitative and qualitative measures (e.g., adherence scores, patient interviews).
Step 6: Identify Barriers and Lessons Learned
Be transparent about challenges and explain how you addressed or plan to address them.
Step 7: Discuss Sustainability and Dissemination
Explain how the design can continue, expand, or inform future practice.
Step 8: Conclude with Reflection
Reflect on how the design enhanced your leadership, practice, and validation-predicated decision-timber.
FAQs: NURS FPX 9020 Assessment 1 – Project Implementation in Practice
1. What’s the purpose of this assessment?
To demonstrate your capability to apply and estimate a DNP design in a real-world clinical setting.
2. Do I need to use factual data?
Yes, this assessment focuses on real or simulated data collected during performance.
3. What length should my paper be?
The paper should generally be 6 to 8 runners long, banning titles and references.
4. What types of data should I include?
Both quantitative issues (numeric data) and qualitative feedback (party tests).
5. What if my design issues were not successful?
That’s respectable! Still, please specify what aspects were unprofitable, the reasons for their failure, and the changes you would apply.
6. How do I ensure ethical compliance?
gain IRB blessing, maintain confidentiality, and secure informed concurrence.
7. How do I present evaluation results?
Use clear tables, maps, or terse summaries to illuminate vital data points.
8. Do I need to include sustainability?
Yes—sustainability and dispersion are critical factors for DNP design success.
